Singing intervention 2 for Cardiovascular Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Medical College of Wisconsin, Milwaukee, WICardiovascular Disease+2 MoreSinging with Music Therapist - Other
Eligibility
55 - 79
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether singing can help improve cardiovascular biomarkers in older patients with CVD.

Eligible Conditions
  • Cardiovascular Health
  • Cardiovascular Disease
  • Cardiovascular Risk

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: after 30-minute singing (and sham) interventions

At baseline and after 30-minute singing and sham intervention(s)
change in vascular (endothelial) function
after 30-minute singing (and sham) interventions
level of exertion achieved during singing
at baseline and 30 minutes later (after interventions or sham)
Visual Mood Score
the change in TNF-alpha, IL-1 Beta, IL-6, and IL-8
at baseline and after 30-minute singing and sham intervention(s)
cardiac hemodynamics

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Singing intervention 2
1 of 3
Singing intervention 1
1 of 3
Control/sham intervention
1 of 3

Active Control

Non-Treatment Group

65 Total Participants · 3 Treatment Groups

Primary Treatment: Singing intervention 2 · Has Placebo Group · N/A

Singing intervention 2
Other
ActiveComparator Group · 1 Intervention: Singing with Music Therapist · Intervention Types: Other
Control/sham intervention
Other
ShamComparator Group · 1 Intervention: Control Arm · Intervention Types: Other
Singing intervention 1
Other
ActiveComparator Group · 1 Intervention: Singing with Guided Video · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: after 30-minute singing (and sham) interventions

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
572 Previous Clinical Trials
1,155,180 Total Patients Enrolled

Eligibility Criteria

Age 55 - 79 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You need to be able to speak English.

Frequently Asked Questions

Am I eligible to become a participant in this medical study?

"All potential participants must be diagnosed with cardiovascular diseases and between the ages of 55 to 79. 65 patients are needed for this clinical trial." - Anonymous Online Contributor

Unverified Answer

What is the capacity of participants for this research endeavor?

"Affirmative. Per the clinicaltrials.gov registry, this research endeavour is still recruiting participants since its launch on January 17th 2020 and recent update of September 24th 2021. 65 individuals need to be enrolled from a single location." - Anonymous Online Contributor

Unverified Answer

Is this research endeavor actively seeking participants?

"Affirmative. According to clinicaltrials.gov, the trial in question is actively seeking participants and was initially posted on January 17th 2020 with a most recent update registered on September 24th 2021. One centre has been identified for recruitment which requires 65 patients to be accepted into the study." - Anonymous Online Contributor

Unverified Answer

Is geriatric recruitment necessary for this clinical investigation?

"As per the study's admission requirements, individuals aged 55 to 79 are eligible for enrollment." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.